Keeping Physicians in Mind and Informed.
COVID-19 Update, 4/27/21
Status Update as of 4/26/21 from ADH Website: 

  • Total cumulative cases in Arkansas - 334,769
  • New confirmed cases since 4/25- 63
  • Active cases - 1,262
  • Deaths -5,720
  • Patients in the hospital - 170
  • Patients on ventilators - 27
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Johnson & Johnson COVID-19 Vaccine

On April 13, 2021, CDC and the Food and Drug Administration (FDA) recommended pausing use of the Johnson & Johnson COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome (TTS) among vaccine recipients.

On April 23, the Advisory Committee on Immunization Practices concluded that the benefits of resuming the Johnson & Johnson COVID-19 vaccination among persons 18 years and over outweighed the risks and reaffirmed its interim recommendation under FDA’s Emergency Use Authorization, which includes a new warning for rare clotting events among women aged 18–49 years.

Resuming use of the Johnson & Johnson COVID-19 vaccine will ensure flexibility, choice, and improved access, but recommends education about TTS risk with Johnson & Johnson COVID-19 vaccine is critical.

View our information on personal protective equipment at
or visit for Arkansas PPE vendors.
View the latest information from insurance carriers, HIPAA, and other sources on telemedicine during the COVID-19 crisis at
Financial Resources
We've compiled all of the financial resources that you may need for your clinic or practice during the COVID-19 crisis at
Got Questions? Let Us Help.

The Arkansas Medical Society is here to serve our physician members and their medical teams. On our website, we have a place that you can send us questions or share what you're experiencing. Visit and click on the Got Questions box. We will respond to your question as soon as possible. Thank you for your hard work and together we will make it through this crisis.
For more AMS COVID-19 Resources, visit